NASDAQ : HYFT
MindWalk Holdings Corp. — Company profile
Healthcare · Biotechnology · United States
Last price 1.2 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 56.53M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company is headquartered in Austin, Texas.
Details
| Name | MindWalk Holdings Corp. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 77 |
| Founded | 1983 |
| Ipo Date | 2017-01-03 |
| Ceo | Jennifer Bath |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| Isin | CA6026871054 |
| Cusip | 602687105 |
| Cik | 1715925 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Dr. Jennifer Lynne Bath Ph.D. | Chief Executive Officer, President and Non-Independent Director |
| Richard Scott Areglado | Chief Financial Officer |
Contact
| Address | Industrious 823 Congress Ave, Suite 300, Austin, Texas 78701, United States |
| Phone | 800 620 4187 |
| Website | https://www.mindwalkai.com |